Author: eRegs & Guides
Publisher: eregs And guides
ISBN:
Category : Law
Languages : en
Pages : 31
Book Description
Financial Conflict Of Interest Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (42 C.F.R. Part 50, Subpart F) Responsible Prospective Contractors (45 C.F.R. Part 94)
Good Clinical Practice eRegs & Guides - For Your Reference Book 7
Author: eRegs & Guides
Publisher: eregs And guides
ISBN:
Category : Law
Languages : en
Pages : 31
Book Description
Financial Conflict Of Interest Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (42 C.F.R. Part 50, Subpart F) Responsible Prospective Contractors (45 C.F.R. Part 94)
Publisher: eregs And guides
ISBN:
Category : Law
Languages : en
Pages : 31
Book Description
Financial Conflict Of Interest Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (42 C.F.R. Part 50, Subpart F) Responsible Prospective Contractors (45 C.F.R. Part 94)
Good Clinical Practice eRegs & Guides - For Your Reference Book 3
Author: eRegs & Guides
Publisher: eRegs And Guides
ISBN:
Category : Business & Economics
Languages : en
Pages : 120
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: ICH Q8 Pharmaceutical Development ICH Q9 Quality Risk Management ICH Q10 Pharmaceutical Quality System
Publisher: eRegs And Guides
ISBN:
Category : Business & Economics
Languages : en
Pages : 120
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: ICH Q8 Pharmaceutical Development ICH Q9 Quality Risk Management ICH Q10 Pharmaceutical Quality System
Good Clinical Practice eRegs & Guides - For Your Reference Book 8
Author: eRegs & Guides
Publisher: eregs & guides
ISBN:
Category : Medical
Languages : en
Pages : 31
Book Description
Guidance for Industry Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring
Publisher: eregs & guides
ISBN:
Category : Medical
Languages : en
Pages : 31
Book Description
Guidance for Industry Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring
Good Clinical Practice eRegs & Guides - For Your Reference Book 2
Author: eRegs & Guides
Publisher: eRegs And Guides
ISBN:
Category : Business & Economics
Languages : en
Pages : 365
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: E6 Good Clinical Practice Guidance for Industry Part 11, Electronic Records; Electronic Signatures — Scope and Application CFR 21-- General Part 11, Electronic Records; Electronic Signatures 21 CFR PART 50 Protection Of Human Subjects 21 CFR Part 54 Financial Disclosure By Clinical Investigators 21 CFR PART 56 Institutional Review Boards Title 21 PART 312 Investigational New Drug Application ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting ICH E8 General Considerations For Clinical Trials
Publisher: eRegs And Guides
ISBN:
Category : Business & Economics
Languages : en
Pages : 365
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: E6 Good Clinical Practice Guidance for Industry Part 11, Electronic Records; Electronic Signatures — Scope and Application CFR 21-- General Part 11, Electronic Records; Electronic Signatures 21 CFR PART 50 Protection Of Human Subjects 21 CFR Part 54 Financial Disclosure By Clinical Investigators 21 CFR PART 56 Institutional Review Boards Title 21 PART 312 Investigational New Drug Application ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting ICH E8 General Considerations For Clinical Trials
Good Clinical Practice eRegs & Guides - For Your Reference Book 9: Regulations & Guidance on Biologics, Blood Products, and Good Tissue Practice
Author: eRegs & Guides
Publisher: eregs & guides
ISBN:
Category : Medical
Languages : en
Pages : 579
Book Description
PART 600 BIOLOGICAL PRODUCTS: GENERAL PART 601 LICENSING PART 606 CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS PART 607 ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS PART 610 GENERAL BIOLOGICAL PRODUCTS STANDARDS PART 630 GENERAL REQUIREMENTS FOR BLOOD, BLOOD COMPONENTS, AND BLOOD DERIVATIVES PART 640 ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS PART 660 ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS PART 680 ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS PART 1270 HUMAN TISSUE INTENDED FOR TRANSPLANTATION PART 1271 HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products
Publisher: eregs & guides
ISBN:
Category : Medical
Languages : en
Pages : 579
Book Description
PART 600 BIOLOGICAL PRODUCTS: GENERAL PART 601 LICENSING PART 606 CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS PART 607 ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS PART 610 GENERAL BIOLOGICAL PRODUCTS STANDARDS PART 630 GENERAL REQUIREMENTS FOR BLOOD, BLOOD COMPONENTS, AND BLOOD DERIVATIVES PART 640 ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS PART 660 ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS PART 680 ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS PART 1270 HUMAN TISSUE INTENDED FOR TRANSPLANTATION PART 1271 HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products
Good Clinical Practice eRegs & Guides - For Your Reference Book 10: Regulations on: Drug Labeling, Drug Advertising, Drug Marketing, Drug Imprinting, Drug Names, Promotional Materials
Author: eRegs & Guides
Publisher: eregs & guides
ISBN:
Category : Law
Languages : en
Pages : 396
Book Description
Regulations on: Drug Labeling, Drug Advertising, Drug Marketing, Drug Imprinting, Drug Names, Promotional Materials PART 99 DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES PART 200 GENERAL PART 201 LABELING PART 202 PRESCRIPTION DRUG ADVERTISING PART 203 PRESCRIPTION DRUG MARKETING PART 206 IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE PART 208 MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS PART 299 DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES SEC. 312.7 PROM0TION OF INVESTIGATIONAL DRUGS SEC. 314.81 OTHER POSTMARKETING REPORTS SEC. 314.550 PROMOTIONAL MATERIALS SEC. 314.560 TERMINATION OF REQUIREMENTS
Publisher: eregs & guides
ISBN:
Category : Law
Languages : en
Pages : 396
Book Description
Regulations on: Drug Labeling, Drug Advertising, Drug Marketing, Drug Imprinting, Drug Names, Promotional Materials PART 99 DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES PART 200 GENERAL PART 201 LABELING PART 202 PRESCRIPTION DRUG ADVERTISING PART 203 PRESCRIPTION DRUG MARKETING PART 206 IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE PART 208 MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS PART 299 DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES SEC. 312.7 PROM0TION OF INVESTIGATIONAL DRUGS SEC. 314.81 OTHER POSTMARKETING REPORTS SEC. 314.550 PROMOTIONAL MATERIALS SEC. 314.560 TERMINATION OF REQUIREMENTS
Good Clinical Practice eRegs & Guides - For Your Reference Book 6
Author: eRegs & Guides
Publisher: eregs & guides
ISBN:
Category : Law
Languages : en
Pages : 334
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: ICH - Safety Guidelines S1A – S9 S1A Guideline on the Need for Carcinogenicity Studies S1B Testing for Carcinogenicity of Pharmaceuticals S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies S4 Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing) S5(R2) Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S7A Safety Pharmacology Studies For Human Pharmaceuticals S7B The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) By Human Pharmaceuticals S8 Immunotoxicity Studies for Human Pharmaceuticals S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
Publisher: eregs & guides
ISBN:
Category : Law
Languages : en
Pages : 334
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: ICH - Safety Guidelines S1A – S9 S1A Guideline on the Need for Carcinogenicity Studies S1B Testing for Carcinogenicity of Pharmaceuticals S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies S4 Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing) S5(R2) Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S7A Safety Pharmacology Studies For Human Pharmaceuticals S7B The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) By Human Pharmaceuticals S8 Immunotoxicity Studies for Human Pharmaceuticals S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
Good Clinical Practice eRegs & Guides - For Your Reference Book 4
Author: eRegs & Guides
Publisher: eregs & guides
ISBN:
Category : Biography & Autobiography
Languages : en
Pages : 390
Book Description
Good Clinical Practice For Your Reference - Book 4 ICH - Clinical Safety E1 - E2F ICH-E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-term Treatment of Non-Life-Threatening Conditions ICH-E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting ICH-E2B(R2) Clinical Safety Data Management : Data Elements for Transmission of Individual Case Safety Reports ICH-E2C(R1) Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs ICH-E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting ICH-E2E Pharmacovigilance Planning ICH-E2F Development Safety Update Report Samples of DSURS European Directive 2001/20/EC European Directive 2005/28/EC
Publisher: eregs & guides
ISBN:
Category : Biography & Autobiography
Languages : en
Pages : 390
Book Description
Good Clinical Practice For Your Reference - Book 4 ICH - Clinical Safety E1 - E2F ICH-E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-term Treatment of Non-Life-Threatening Conditions ICH-E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting ICH-E2B(R2) Clinical Safety Data Management : Data Elements for Transmission of Individual Case Safety Reports ICH-E2C(R1) Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs ICH-E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting ICH-E2E Pharmacovigilance Planning ICH-E2F Development Safety Update Report Samples of DSURS European Directive 2001/20/EC European Directive 2005/28/EC
Good Clinical Practice eRegs & Guides - For Your Reference Book 5
Author: eRegs & Guides
Publisher: eregs & guides
ISBN:
Category : Business & Economics
Languages : en
Pages : 466
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: Good Clinical Practice For Your Reference - Book 5 ICH - Efficacy Guidelines E3 – E15 ICH-E3: Clinical Study Reports ICH-E3 - Structure and Content of Clinical Study Reports ICH-E4: Dose-Response Information to Support Drug Registration ICH-E5: Ethnic Factors in the Acceptability of foreign Clinical Data ICH-E6: Guideline for Good Clinical Practice ICH-E7: Studies in Support of Special Populations: Geriatrics ICH-E8: General Considerations for Clinical Trials ICH-E9: Statistical Principles for Clinical Trials ICH E-10: Choice of Control Group and Related Issues in Clinical Trials ICH-E11: Clinical Investigation of Medicinal Products in the Pediatric Population ICH-E12: Draft ICH Consensus Principle Principles for Clinical Evaluation of New Antihypertensive Drugs ICH-E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs ICH-E15: Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories
Publisher: eregs & guides
ISBN:
Category : Business & Economics
Languages : en
Pages : 466
Book Description
Good Clinical Practice eRegs & Guides provides a reference to key US FDA Guides and regulations via your electronic reader. An excellent way to access the reference documents on your e-reader. No need to carry paper books and you can search for key terms. In this issue you will find: Good Clinical Practice For Your Reference - Book 5 ICH - Efficacy Guidelines E3 – E15 ICH-E3: Clinical Study Reports ICH-E3 - Structure and Content of Clinical Study Reports ICH-E4: Dose-Response Information to Support Drug Registration ICH-E5: Ethnic Factors in the Acceptability of foreign Clinical Data ICH-E6: Guideline for Good Clinical Practice ICH-E7: Studies in Support of Special Populations: Geriatrics ICH-E8: General Considerations for Clinical Trials ICH-E9: Statistical Principles for Clinical Trials ICH E-10: Choice of Control Group and Related Issues in Clinical Trials ICH-E11: Clinical Investigation of Medicinal Products in the Pediatric Population ICH-E12: Draft ICH Consensus Principle Principles for Clinical Evaluation of New Antihypertensive Drugs ICH-E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs ICH-E15: Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories
Bentley's Textbook of Pharmaceutics - E-Book
Author: Sanjay Kumar Jain
Publisher: Elsevier Health Sciences
ISBN: 8131232662
Category : Medical
Languages : en
Pages : 778
Book Description
This adaptation of Bentley's Textbook of Pharmaceutics follows the same goals as those of the previous edition, albeit in a new look. The content of the old edition has been updated and expanded and several new chapters, viz. Complexations, Stability Testing as per ICH Guidelines, Parenteral Formulations, New Drug Delivery Systems and Pilot Plant Manufacturing, have been included, with an intention to make the book more informative for the modern pharmacists. The book has six sections: - Section I deals with the physicochemical principles. Two new chapters: Complexations and ICH Guidelines for Stability Testing, have been added to make it more informative. - Section II conveys the information regarding pharmaceutical unit operations and processes. - Section III describes the area of pharmaceutical practice. Extensive recent updates have been included in many chapters of this section. Two new chapters: Parenteral Formulations and New Drug Delivery Systems, have been added. - Section IV contains radioactivity principles and applications. - Section V deals with microbiology and animal products. - Section VI contains the formulation and packaging aspects of pharmaceuticals. Pilot Plant Manufacturing concepts are added as a new chapter, which may be beneficial to readers to understand the art of designing of a plant from the pilot plant model.
Publisher: Elsevier Health Sciences
ISBN: 8131232662
Category : Medical
Languages : en
Pages : 778
Book Description
This adaptation of Bentley's Textbook of Pharmaceutics follows the same goals as those of the previous edition, albeit in a new look. The content of the old edition has been updated and expanded and several new chapters, viz. Complexations, Stability Testing as per ICH Guidelines, Parenteral Formulations, New Drug Delivery Systems and Pilot Plant Manufacturing, have been included, with an intention to make the book more informative for the modern pharmacists. The book has six sections: - Section I deals with the physicochemical principles. Two new chapters: Complexations and ICH Guidelines for Stability Testing, have been added to make it more informative. - Section II conveys the information regarding pharmaceutical unit operations and processes. - Section III describes the area of pharmaceutical practice. Extensive recent updates have been included in many chapters of this section. Two new chapters: Parenteral Formulations and New Drug Delivery Systems, have been added. - Section IV contains radioactivity principles and applications. - Section V deals with microbiology and animal products. - Section VI contains the formulation and packaging aspects of pharmaceuticals. Pilot Plant Manufacturing concepts are added as a new chapter, which may be beneficial to readers to understand the art of designing of a plant from the pilot plant model.